Chronic spontaneous urticaria
Clinical trials for Chronic spontaneous urticaria explained in plain language.
Never miss a new study
Get alerted when new Chronic spontaneous urticaria trials appear
Sign up with your email to follow new studies for Chronic spontaneous urticaria, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a Two-Drug sequence tame chronic hives?
Disease control Not yet recruitingResearchers are testing a treatment plan that uses two drugs, remibrutinib and omalizumab, in adults with chronic spontaneous urticaria whose hives and itching are not controlled by standard antihistamines. The study follows about 382 adults across multiple centers worldwide. The…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New drug HRS-3095 aims to soothe stubborn hives
Symptom relief Not yet recruitingThis Phase 2 trial tests whether the experimental drug HRS-3095 can reduce itching and wheals in adults with chronic spontaneous urticaria (hives) that isn't well controlled by antihistamines. About 190 participants will receive either the drug or a placebo daily for 4 weeks. The…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA
Phase 2 • Sponsor: Chengdu Suncadia Medicine Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New shot could tame stubborn hives for good
Symptom relief Not yet recruitingThis study tests a new medicine called MG-K10 for people with chronic hives (itchy welts) that don't get better with standard allergy pills. About 226 teens and adults will receive either the drug or a placebo injection every few weeks. The goal is to see if MG-K10 reduces itchin…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA
Phase 3 • Sponsor: Shanghai Mabgeek Biotech.Co.Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC